Conno Christou doesn’t depart issues to likelihood. He tracks his sleep with a Whoop band, cross-references it with an Oura ring, and will get practically 100 biomarkers checked yearly. He had been doing the annual bloodwork for 4 consecutive years, following the protocols of longevity researchers like Peter Attia and Rhonda Patrick. He was optimizing his dietary supplements, his circadian rhythm, his protein consumption.
At 35, constructing his second firm, he was as dialed-in on the most recent in well being analysis as anybody he knew. His final checkup, in 2025, was inexperienced throughout the board. “It was one of the best I’d had in years,” he says.
Then, after a exercise, his arm swelled.
He didn’t assume a lot of it at first. Per week handed earlier than he noticed a health care provider, who discovered two blood clots in his veins and scheduled surgical procedure. However the pre-op exams modified every part. A physician walked again into the room and informed him the process wasn’t occurring.
“We see an 11-by-11-by-8 centimeter mass behind your sternum,” the physician mentioned.
A biopsy confirmed what Christou had by no means earlier than even contemplated. He had an aggressive, fast-growing type of non-Hodgkin’s lymphoma — a uncommon analysis affecting roughly one in 420,000 folks, brought on by a random genetic mutation with no connection to life-style, weight loss plan, or stress.
The tumor had solely existed for about three months. In three extra weeks, it might have reached stage 4.
“Fortunate in my unluckiness,” Christou informed this editor this week from his house in Athens, the place he lives half time. “It was solely discovered as a result of I went in for one thing else completely.”
What adopted was an training within the limits of the medical system, and in what a decided affected person can do about that with instruments now accessible.
His first oncologist, a famend specialist, really helpful the lighter of two accessible chemotherapy regimens. Christou booked his first infusion three days out. Then, the night time earlier than, he sought a second opinion.
That second physician didn’t hesitate. He really helpful the more durable routine — steady in-hospital infusion, biking each three weeks throughout six months — citing Christou’s particular pathology. The lighter remedy carried roughly a 60% success charge for his presentation. The aggressive one introduced that quantity to round 85%. Two world-class medical doctors. Diametrically reverse suggestions.
“As founders, we maintain the wheel,” Christou says of the propensity of many individuals to simply accept what they’re informed — and why extra shouldn’t. “You hear many issues. You don’t must comply with the primary recommendation.”
He didn’t decide to only comply with the recommendation of the second doctor, both. Over the following two days, he gathered 12 opinions in whole — drawing on his skilled community, reaching out to hematologists and oncologists within the US and overseas, calling in each favor he may. Eleven to 1 voted in favor of the more durable path. He took it. The choice, he says, didn’t really feel courageous a lot as logical. He was already a data-driven particular person, and now the stakes felt existential to him.
Over six months of remedy, Christou approached chemotherapy the way in which he approached constructing an organization, as a marathon of sprints — every of them with a finite cycle and every week crammed with knowledge factors. He had accomplished a compulsory 25-month navy service in Cyprus at age 18 and he borrowed from that have, too. He was going to be a very good soldier, he informed himself. Belief the method. Six cycles. Get by it.
He wore his Whoop all through, and located it remarkably correct at predicting the times his immune system would backside out, typically flagging them earlier than signs arrived. He saved a symptom journal utilizing voice transcription, logging each shift, each facet impact, each treatment and counter-medication. He narrowed his focus to 3 variables: sleep, diet, and, before everything, psychology. (“It strikes the needle greater than something,” mentioned Christou. “I by no means requested ‘why me’ — not as soon as. That query has no helpful reply.”)
He fed all of it — blood outcomes, scan knowledge, wearable output, journal entries — into Claude. He’s removed from alone in turning to chatbots for medical steering. A public opinion poll launched in March discovered {that a} third of American adults now use them for well being info and recommendation. The stories accumulating on-line recommend that for some sufferers, AI is delivering what the system couldn’t.
Specialists urge warning; Danielle Bitterman, scientific lead for knowledge science and AI at Mass Basic Brigham, has informed the New York Instances in current months that general-purpose chatbots are frequently wrong and “haven’t been totally evaluated” for customized diagnoses.
Christou doesn’t disagree. “It didn’t substitute the medical doctors,” he says, however it “helped me ask the precise questions.”
For a situation as uncommon as his — one an oncologist may see yearly — entry to a mannequin that had absorbed the total physique of medical literature was, he says, merely not the identical as a Google search.
The mannequin proved essential on the finish of remedy. His last PET scan — the imaging used to detect energetic illness — got here again ambiguous. His oncologist started discussing a second line of remedy, probably radiotherapy, close to his coronary heart and lungs. It was an alarming improvement.
Christou once more did his homework. He learn that for this particular lymphoma, the false-positive charge on end-of-treatment PET scans is round 60% — a statistic that also astonishes him. “It’s 2026,” he says. “Sixty %.”
He fed all three of his PET scans and his MRI into Claude, which flagged a recognized however simply ignored phenomenon: in sufferers below 40 recovering from this kind of lymphoma, the thymus gland can reactivate after chemotherapy, displaying up on imaging as what seems to be energetic illness. Given his age, his particular scan traits, the mannequin put the chance of that clarification at roughly 90%.
He sought three extra opinions. The fourth physician confirmed it: thymus rebound. There was no energetic illness. No radiotherapy was wanted. He was clear.
Christou remains to be unfolding what the final yr has meant, for his well being, how he works, and the way he thinks about time. He constructed Keragon, his present firm, earlier than any of this occurred; it’s an AI-powered platform that helps medical practices automate their administrative operations.
However going by the system as a affected person has given him new perspective. He watched nurses and medical doctors buried below duties that had nothing to do with care. He acquired the identical chemotherapy protocol as an 80-year-old girl, the unwanted effects managed by a cascading chain of further medication, every inflicting issues of their very own. He says he’s sure that we are going to look again at this period of remedy and cringe.
He takes Sundays off now, principally. He tries to be current — at lunch with buddies, at house along with his canine, in conversations which may as soon as have felt like a distraction from work. A VC good friend informed him one thing years in the past that he mentioned he saved replaying throughout remedy: Be glad now. He says it’s among the many hardest issues to do and but he lastly appreciates its significance.
He says he’d be glad to speak to anybody going by one thing just like share notes, examine experiences. He appears to means it.
“It’s not occurring in 10 years,” he says of what AI can already do for sufferers prepared to make use of it. “It’s occurring in the present day.”
Once you buy by hyperlinks in our articles, we may earn a small commission. This doesn’t have an effect on our editorial independence.